The House of Lords Science and Technology Committee have published its report on the Life Sciences Industrial Strategy. The BIA submitted written evidence to the inquiry last Autumn and BIA CEO Steve Bates also gave oral evidence to the Committee. Today the BIA has responded to the release of the report.
April was a mixed month – showing both the frailty and the strength of the bio-investing world. Also this month, we discuss IPOs and introduce the investor, Advent International – a private equity specialist.
Business Secretary Greg Clark and Science Minister Sam Gyimah officially opened centre to ‘bridge the gap’ between scientific research and commercialisation of the medicines of the future. Over £60 million of Industrial Strategy investment is being used to develop the new centre.
The BIA Chief Medical Officer Summit was a new event held in early March aimed at supporting the skills required to be a CMO in an SME. Here, Dr Penny Ward, CMO of Karus Therapeutics, and vice-Chair of the BIA Science and Innovation Advisory Committee, takes a look at some of the highlights from the day.
It was great to see so many BIA members at the official opening of the Cell and Gene Therapy Catapult’s new GMP manufacturing centre in Stevenage today. The formalities were done by Business Secretary Greg Clark MP, and Science and Universities Minister Sam Gymiah MP, but what inspired me was the way in which UK SME engagement has been the hallmark of the project to this point. Initial collaborators Autolus, Cell Medica, AdaptImmune, Thermo Fisher Scientific as well as the Cell and Gene Therapy Catapult itself are BIA members so for me it’s fantastic to see the power of our community using the Industrial Strategy we’ve advocated to move this important part of our sector forward.
Synpromics announces a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals. The project has been made possible through the award of a £235,000 grant from Innovate UK.
Clinical bioinformaticians work to make genome data clinically actionable; to make sense of large amounts of data so that other healthcare professionals can use it to inform decisions about diagnosis, treatment and care. They straddle the worlds of biology and computer programming to provide a vital link in the patient pathway.
This film from the Genomics Education Programme showcases what the work of a clinical bioinformatician involves, the kind of traits and skills required, and some of the challenges facing both those working in the profession and the NHS more broadly.
Oxford, UK, 19 April 2018 – Oxford Sciences Innovation (OSI), which invests in world-leading science and technology from the University of Oxford, is expanding at The Oxford Science Park, one of the UK's leading parks for science and technology companies.
CAMS-UK (Community for Analytical Measurement Science-UK) is an industrially-led, strategically connected community dedicated to supply world class analytical measurement science (AMS) training, research and innovation. A one-day launch meeting for the CAMS-UK Industry Steering Panel is being held on 03 May 2018 which will include an interactive workshop designed to help shape both the top training thematic areas and measurement challenges.